Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy
Aspirin resistance describes a phenomenon where patients receiving aspirin therapy do not respond favorably to treatment, and is categorized by continued incidence of adverse cardiovascular events and/or the lack of reduced platelet reactivity. Studies demonstrate that one in four patients with vasc...
Main Authors: | Hamzah Khan, Omar Kanny, Muzammil H. Syed, Mohammad Qadura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/19/11317 |
Similar Items
-
Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
by: Hamzah Khan, et al.
Published: (2021-12-01) -
Aspirin resistance: causes, clinical significance, correction
by: G.F. Gendeleka, et al.
Published: (2022-04-01) -
Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
by: Hamzah Khan, et al.
Published: (2022-08-01) -
Effect of madecassoside combined with aspirin on platelet functions
by: Theiarawat Kraikate, et al.
Published: (2015-09-01) -
Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)